GSK plc ( GSK) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Ladies and gentlemen, a very warm welcome to the GSK Q3 2025 Results Call. I'm delighted to be joined today by Emma Walmsley, Luke ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates ...

BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...

Q3 2025 Earnings Call Transcript October 29, 2025 Smurfit Westrock Plc misses on earnings expectations. Reported EPS is $0.55 EPS, expectations were $0.68. Operator: Good day, and thank you for ...

Accenture (NYSE: ACN) invests in Lyzr, an AI platform for enterprises in banking, insurance, and financial services.

Lyzr will join Accenture Ventures’ Project Spotlight, a vertical accelerator program that provides AI companies with access ...

QPR SOFTWARE PLC STOCK EXCHANGE RELEASE 31 October 2025, AT 9.00 AM EETQPR Software Plc Interim Report January-September 2025: The company's SaaS net sales grew by 2%. QPR ProcessAnalyzer's ...

London: GSK plc and Syndivia, a private biotechnology company focused on next-generation ADCs, have announced an agreement ...

Cigna Group will eliminate prescription drug rebates in many of its commercial health plans in 2027, upending an opaque, controversial practice that’s drawn the ire of President Donald Trump.

Lyzr will join Accenture Ventures’ Project Spotlight, a vertical accelerator program that provides AI companies with access to Accenture’s domain expertise and enterprise clients. The company is also ...

(NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Euan Ashley to its Board of Directors, effective October 24, 2025. Dr. Ashley is a renowned researcher, ...

Together with the City of Amsterdam and its partners, Monks—S4 Capital's global, purely digital, unitary operating brand—launches ...